SCHEMBL1726207

SCHEMBL1726207

CCn1cc2c(Oc3cnc(C(=O)N(C(OC)(OC)c4ccccc4)C(OC)(OC)c4ccccc4)cn3)cc(C(=O)Nc3ccc(C)cn3)cc2n1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 19/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1725510 0.86 GCK (0.66) GCK
SCHEMBL1721931 0.83 GCK (0.53) GCK
SCHEMBL1726205 0.83 GCK (0.49) GCK
SCHEMBL1726203 0.81 GCK (0.49) GCK
SCHEMBL1721828 0.80 GCK (0.59) GCK
SCHEMBL1723743 0.80 GCK (0.49) GCK
SCHEMBL1722267 0.78 GCK (0.51) GCK
SCHEMBL1722190 0.77 GCK (0.81) GCK
SCHEMBL1724135 0.77 GCK (0.80) GCK
SCHEMBL1723406 0.72 GCK (0.82) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406230-A1 SUBSTITUTED INDAZOLE AMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS Pfizer Inc. (US) 2012-01-18 EP disclosed
WO-2010103438-A1 SUBSTITUTED INDAZOLE AMIDES AND THEIR USE AS GLUCOKINASE ACTIVATORS PFIZER INC. (US) 2010-09-16 WO disclosed